Your browser doesn't support javascript.
loading
The outcomes of considering goals of care in medication reviews for older adults: a systematic review.
Masnoon, Nashwa; George, Cristen; Lo, Sarita; Tan, Edwin; Bordia, Aagam; Hilmer, Sarah.
Afiliación
  • Masnoon N; Kolling Institute, Faculty of Medicine and Health, University of Sydney and Northern Sydney Local Health District, Sydney, NSW, Australia.
  • George C; Kolling Institute, Faculty of Medicine and Health, University of Sydney and Northern Sydney Local Health District, Sydney, NSW, Australia.
  • Lo S; School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Tan E; Kolling Institute, Faculty of Medicine and Health, University of Sydney and Northern Sydney Local Health District, Sydney, NSW, Australia.
  • Bordia A; School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Hilmer S; Kolling Institute, Faculty of Medicine and Health, University of Sydney and Northern Sydney Local Health District, Sydney, NSW, Australia.
Expert Rev Clin Pharmacol ; 17(1): 33-56, 2024 Jan.
Article en En | MEDLINE | ID: mdl-38145414
ABSTRACT

INTRODUCTION:

This is a systematic review of prescribing, clinical, patient-reported, and health utilization outcomes of goal-directed medication reviews in older adults.

METHODS:

A systematic review was conducted using MEDLINE, EMBASE, SCOPUS and CINAHL databases to identify studies examining outcomes of goal-directed medication reviews in humans, with mean/median age ≥ 60 years and in English.

RESULTS:

Seventeen out of 743 articles identified were included. Whilst there were inconsistent findings regarding changes in the number of medications between groups or post-intervention in one group (n = 6 studies), studies found reductions in drug-related problems (n = 2) and potential to reduce anticholinergics and sedatives (n = 2). Two out of seven studies investigating clinical outcomes found improvements, such as reduced hospital readmissions and improved depression severity. One study found 75% of patients achieved ≥ 1 goals and another found 43% of goals were achieved at six months. Four out of five studies found significant improvements in patient-reported quality of life between groups (n = 2) or post-intervention in one group (n = 2). Both studies investigating cost-effectiveness reported the intervention was cost-effective.

CONCLUSIONS:

There is evidence of positive impact on medication rationalization, quality of life and cost-effectiveness, supporting goal-directed medication reviews. Larger, longitudinal studies, exploring patient-focused outcomes may provide further insights into the ongoing impact of goal-directed medication reviews.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Planificación de Atención al Paciente / Revisión de Medicamentos Tipo de estudio: Systematic_reviews Límite: Aged / Humans / Middle aged Idioma: En Revista: Expert Rev Clin Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Planificación de Atención al Paciente / Revisión de Medicamentos Tipo de estudio: Systematic_reviews Límite: Aged / Humans / Middle aged Idioma: En Revista: Expert Rev Clin Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Australia